Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ADAMTS13 regulates angiogenic markers via Ephrin/Eph signaling in human mesenchymal stem cells under serum-deprivation stress. | Sci Rep | 2024 | 38177376 | PubTator, text mining | PubMed |
| The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer. | J Exp Clin Cancer Res | 2024 | 38163859 | PubTator, text mining | PubMed |
| Subcellular RNA distribution and its change during human embryonic stem cell differentiation. | Stem Cell Reports | 2024 | 38134924 | PubTator, text mining | PubMed |
| The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention. | Oncogene | 2024 | 38081962 | PubTator, text mining | PubMed |
| One health and bat-borne henipaviruses. | New Microbes New Infect | 2024 | 38035121 | PubTator, text mining | PubMed |
| Listen to Your Gut: Key Concepts for Bioengineering Advanced Models of the Intestine. | Adv Sci (Weinh) | 2024 | 38009508 | PubTator, text mining | PubMed |
| Biological Significance of EphB4 Expression in Cancer. | Curr Protein Pept Sci | 2024 | 37909437 | PubTator, text mining | PubMed |
| Advances in cardiac tissue engineering and heart-on-a-chip. | J Biomed Mater Res A | 2024 | 37909362 | PubTator, text mining | PubMed |
| Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions. | Genes Dis | 2024 | 37692522 | PubTator, text mining | PubMed |
| Metabolic and proteostatic differences in quiescent and active neural stem cells. | Neural Regen Res | 2024 | 37488842 | PubTator, text mining | PubMed |
| A Multimodal Omics Framework to Empower Target Discovery for Cardiovascular Regeneration. | Cardiovasc Drugs Ther | 2024 | 37421484 | PubTator, text mining | PubMed |
| Ephrin B/EphB in neuropathic pain: Role and molecular mechanisms. | Fundam Clin Pharmacol | 2024 | 37401197 | PubTator, text mining | PubMed |
| A narrative review of the role of Eph receptors in head and neck squamous cell carcinoma. | Oral Dis | 2024 | 37279081 | PubTator, text mining | PubMed |
| Octacalcium phosphate, a promising bone substitute material: a narrative review. | J Yeungnam Med Sci | 2024 | 37157781 | PubTator, text mining | PubMed |
| An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors. | Mol Divers | 2024 | 36847923 | PubTator, text mining | PubMed |
Evaluation of the interaction between potent small molecules against the Nipah virus Glycoprotein in Malaysia and Bangladesh strains, accompanied by the human Ephrin-B2 and Ephrin-B3 receptors; a simulation approach. | Mol Divers | 2024 | 36808582 | PubTator, text mining | PubMed |
| A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma. | Front Oncol | 2023 | 38304027 | PubTator, text mining | PubMed |
| Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells. | Biomolecules | 2023 | 38275745 | PubTator, text mining | PubMed |
| Current perspectives and trends in the treatment of brain arteriovenous malformations: a review and bibliometric analysis. | Front Neurol | 2023 | 38274874 | PubTator, text mining | PubMed |
| Women's contribution to stem cell research for osteoarthritis: an opinion paper. | Front Cell Dev Biol | 2023 | 38174070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=10